Secure Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.51M Buy
47,105
+3,459
+8% +$347K 0.77% 33
2026
Q1
$4.03M Sell
43,646
-6,738
-13% -$634K 0.64% 41
2025
Q4
$3.98M Buy
50,384
+1,943
+4% +$139K 0.62% 35
2025
Q3
$3.54M Sell
48,441
-2,556
-5% -$162K 0.58% 46
2025
Q2
$2.6M Buy
50,997
+2,087
+4% +$92.9K 0.48% 54
2025
Q1
$2.2M Buy
48,910
+8,990
+23% +$424K 0.44% 69
2024
Q4
$1.65M Buy
39,920
+3,406
+9% +$142K 0.25% 97
2024
Q3
$1.42M Sell
36,514
-9,390
-20% -$375K 0.24% 106
2024
Q2
$1.57M Buy
45,904
+3,630
+9% +$95.2K 0.3% 79
2024
Q1
$1.06M Buy
42,274
+3,071
+8% +$84.4K 0.25% 102
2023
Q4
$1.16M Sell
39,203
-495
-1% -$15K 0.31% 85
2023
Q3
$1.25M Buy
39,698
+4,144
+12% +$113K 0.38% 59
2023
Q2
$920K Sell
35,554
-3,451
-9% -$91.8K 0.28% 88
2023
Q1
$937K Sell
39,005
-4,167
-10% -$95K 0.31% 78
2022
Q4
$842K Buy
+43,172
New +$853K 0.3% 85

Other funds holding MIRM

Secure Asset Management's MIRM Position: Q2 2026 in Review

Secure Asset Management increased its Mirum Pharmaceuticals (MIRM) stake by 7.9% in Q2 2026, buying an estimated $347K and bringing the position to 47,105 shares worth $5.51M. The position accounts for 0.77% of the portfolio, ranked #33.

Secure Asset Management first reported a position in MIRM in Q4 2022 and has held it in 15 quarters since. 22 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Secure Asset Management held 47,105 shares of Mirum Pharmaceuticals worth $5.51M as of Q2 2026.
  • Secure Asset Management bought 3,459 Mirum Pharmaceuticals shares in Q2 2026, an estimated $347K.
  • Mirum Pharmaceuticals made up 0.77% of Secure Asset Management's portfolio in Q2 2026, its #33 holding.
  • Secure Asset Management first reported a position in Mirum Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • 22 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Secure Asset Management's 13F filing for Q2 2026, filed 15 Jul 2026.